Hilltop Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
3,581
-215
| -6% | -$39.9K | 0.2% | 62 |
|
|
2025
Q1 | $795K | Sell |
3,796
-24
| -0.6% | -$5.03K | 0.27% | 53 |
|
|
2024
Q4 | $679K | Sell |
3,820
-43
| -1% | -$7.64K | 0.23% | 60 |
|
|
2024
Q3 | $763K | Buy |
3,863
+4
| +0.1% | +$790 | 0.26% | 59 |
|
|
2024
Q2 | $662K | Buy |
3,859
+55
| +1% | +$9.43K | 0.24% | 58 |
|
|
2024
Q1 | $693K | Buy |
3,804
+2
| +0.1% | +$364 | 0.25% | 57 |
|
|
2023
Q4 | $589K | Buy |
3,802
+123
| +3% | +$19.1K | 0.23% | 55 |
|
|
2023
Q3 | $548K | Sell |
3,679
-15
| -0.4% | -$2.24K | 0.23% | 57 |
|
|
2023
Q2 | $498K | Buy |
3,694
+615
| +20% | +$82.9K | 0.21% | 61 |
|
|
2023
Q1 | $491K | Buy |
3,079
+6
| +0.2% | +$956 | 0.22% | 41 |
|
|
2022
Q4 | $497K | Buy |
+3,073
| New | +$497K | 0.27% | 30 |
|